Vriligy 60 Mg contains the active ingredient dapoxetine, a selective serotonin reuptake inhibitor (SSRI) that is used to treat premature ejaculation. By increasing serotonin levels in the brain, dapoxetine helps to delay ejaculation and improve control over orgasm. It is specifically designed for short-term use and is typically taken just before sexual activity. While Vriligy 60 Mg effectively addresses premature ejaculation, it does not directly treat erectile dysfunction. This distinction is crucial when considering combination therapies for patients who experience both conditions simultaneously. Combining Vriligy 60 Mg with PDE5 inhibitors could potentially offer a comprehensive solution for men experiencing both ED and PE. The rationale behind this combination is straightforward: While Vriligy addresses the timing of ejaculation, PDE5 inhibitors address the physiological aspect of achieving and maintaining an erection.